Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 9 | 2024 | 3224 | 0.920 |
Why?
|
| Pericarditis, Constrictive | 1 | 2021 | 46 | 0.740 |
Why?
|
| Pericardiectomy | 1 | 2021 | 46 | 0.740 |
Why?
|
| Retinal Diseases | 2 | 2023 | 702 | 0.670 |
Why?
|
| Hypertension, Renovascular | 1 | 2018 | 117 | 0.600 |
Why?
|
| Renin | 1 | 2018 | 635 | 0.530 |
Why?
|
| Heart Neoplasms | 1 | 2017 | 360 | 0.460 |
Why?
|
| Oxidative Stress | 3 | 2021 | 3106 | 0.430 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2019 | 3620 | 0.360 |
Why?
|
| Kidney Transplantation | 2 | 2022 | 4214 | 0.340 |
Why?
|
| Mitochondria | 2 | 2022 | 3601 | 0.320 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2018 | 1200 | 0.310 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2018 | 1425 | 0.300 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2023 | 1112 | 0.280 |
Why?
|
| Diagnostic Imaging | 1 | 2021 | 3527 | 0.270 |
Why?
|
| Drug-Eluting Stents | 2 | 2022 | 757 | 0.240 |
Why?
|
| Endovascular Procedures | 1 | 2018 | 2134 | 0.230 |
Why?
|
| Transcription Factors | 1 | 2023 | 12102 | 0.230 |
Why?
|
| Heart-Assist Devices | 2 | 2024 | 1291 | 0.210 |
Why?
|
| Kidney | 1 | 2018 | 7064 | 0.210 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2022 | 62 | 0.190 |
Why?
|
| Biology | 1 | 2023 | 290 | 0.190 |
Why?
|
| Coronary Artery Disease | 4 | 2022 | 6659 | 0.180 |
Why?
|
| Rats, Wistar | 3 | 2019 | 1849 | 0.180 |
Why?
|
| Antilymphocyte Serum | 1 | 2021 | 482 | 0.170 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2022 | 479 | 0.160 |
Why?
|
| Pacemaker, Artificial | 1 | 2024 | 815 | 0.150 |
Why?
|
| Vascular Surgical Procedures | 2 | 2018 | 1469 | 0.150 |
Why?
|
| Resistin | 1 | 2019 | 172 | 0.150 |
Why?
|
| Aortic Diseases | 1 | 2024 | 734 | 0.150 |
Why?
|
| Crocus | 1 | 2017 | 9 | 0.150 |
Why?
|
| Cardioplegic Solutions | 1 | 2017 | 122 | 0.140 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2017 | 93 | 0.140 |
Why?
|
| MicroRNAs | 2 | 2023 | 3787 | 0.140 |
Why?
|
| Acute Kidney Injury | 2 | 2021 | 1941 | 0.140 |
Why?
|
| Orchiectomy | 1 | 2019 | 470 | 0.140 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2021 | 2290 | 0.140 |
Why?
|
| Sarcoidosis | 1 | 2022 | 520 | 0.130 |
Why?
|
| Protective Agents | 1 | 2017 | 150 | 0.130 |
Why?
|
| Heart Arrest, Induced | 1 | 2017 | 357 | 0.130 |
Why?
|
| Adipose Tissue, White | 1 | 2018 | 365 | 0.130 |
Why?
|
| Acetylcysteine | 1 | 2017 | 264 | 0.130 |
Why?
|
| Sirtuin 1 | 1 | 2016 | 247 | 0.130 |
Why?
|
| Carotid Body Tumor | 1 | 2015 | 34 | 0.120 |
Why?
|
| Atherosclerosis | 2 | 2024 | 3518 | 0.120 |
Why?
|
| Diabetes Mellitus | 2 | 2024 | 5890 | 0.120 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2016 | 461 | 0.120 |
Why?
|
| Myocardial Revascularization | 1 | 2018 | 841 | 0.120 |
Why?
|
| Plant Extracts | 1 | 2017 | 496 | 0.110 |
Why?
|
| Hypogonadism | 1 | 2019 | 801 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 3484 | 0.100 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2024 | 1518 | 0.100 |
Why?
|
| Antioxidants | 2 | 2017 | 1667 | 0.100 |
Why?
|
| Humans | 31 | 2024 | 760613 | 0.100 |
Why?
|
| Heart Valve Prosthesis | 1 | 2021 | 1495 | 0.100 |
Why?
|
| Cell Cycle Proteins | 1 | 2023 | 3448 | 0.100 |
Why?
|
| Oxygen | 1 | 2023 | 4193 | 0.100 |
Why?
|
| Apolipoproteins E | 1 | 2017 | 1437 | 0.100 |
Why?
|
| Proteomics | 3 | 2022 | 3817 | 0.100 |
Why?
|
| Peripheral Arterial Disease | 1 | 2023 | 1305 | 0.100 |
Why?
|
| Graft Rejection | 2 | 2022 | 4426 | 0.100 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2021 | 1419 | 0.100 |
Why?
|
| Treatment Outcome | 11 | 2023 | 64981 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 1 | 2022 | 1570 | 0.090 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2021 | 1582 | 0.090 |
Why?
|
| Metabolome | 1 | 2017 | 982 | 0.090 |
Why?
|
| Hepatitis C | 1 | 2021 | 1579 | 0.090 |
Why?
|
| Coronary Artery Bypass | 4 | 2022 | 2272 | 0.090 |
Why?
|
| Reperfusion Injury | 1 | 2017 | 1023 | 0.090 |
Why?
|
| Cytokines | 3 | 2022 | 7344 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2022 | 4353 | 0.080 |
Why?
|
| Animals | 10 | 2024 | 167960 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2023 | 5795 | 0.080 |
Why?
|
| Heart Failure | 2 | 2023 | 11848 | 0.080 |
Why?
|
| Proteome | 1 | 2018 | 1855 | 0.080 |
Why?
|
| Rats | 3 | 2022 | 23709 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 4167 | 0.080 |
Why?
|
| Liver Diseases | 1 | 2017 | 1302 | 0.080 |
Why?
|
| Tissue Donors | 3 | 2023 | 2314 | 0.080 |
Why?
|
| Pulmonary Embolism | 1 | 2022 | 2543 | 0.080 |
Why?
|
| Testosterone | 1 | 2019 | 2470 | 0.080 |
Why?
|
| Aortic Valve Stenosis | 1 | 2021 | 2065 | 0.080 |
Why?
|
| Lipids | 1 | 2019 | 3336 | 0.070 |
Why?
|
| Myocardial Ischemia | 1 | 2018 | 2164 | 0.070 |
Why?
|
| Intestines | 1 | 2017 | 1907 | 0.070 |
Why?
|
| Constriction, Pathologic | 2 | 2022 | 1098 | 0.070 |
Why?
|
| Obesity, Morbid | 1 | 2018 | 1287 | 0.070 |
Why?
|
| Mice | 6 | 2024 | 81209 | 0.070 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3226 | 0.070 |
Why?
|
| Heart Diseases | 1 | 2019 | 2809 | 0.060 |
Why?
|
| Embolization, Therapeutic | 1 | 2015 | 1412 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2019 | 3959 | 0.060 |
Why?
|
| Echocardiography | 1 | 2017 | 4981 | 0.060 |
Why?
|
| Ischemia | 2 | 2023 | 1893 | 0.060 |
Why?
|
| Renal Dialysis | 2 | 2024 | 1801 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2017 | 3127 | 0.060 |
Why?
|
| Rats, Zucker | 1 | 2022 | 132 | 0.050 |
Why?
|
| Male | 16 | 2022 | 359718 | 0.050 |
Why?
|
| Inhibins | 1 | 2023 | 209 | 0.050 |
Why?
|
| Early Growth Response Transcription Factors | 1 | 2022 | 31 | 0.050 |
Why?
|
| Interleukin-9 | 1 | 2022 | 61 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2024 | 14374 | 0.050 |
Why?
|
| Postoperative Complications | 3 | 2023 | 15679 | 0.050 |
Why?
|
| Hypertension | 1 | 2022 | 8595 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 3332 | 0.050 |
Why?
|
| Time Factors | 3 | 2018 | 40139 | 0.050 |
Why?
|
| Adult | 9 | 2022 | 220007 | 0.050 |
Why?
|
| Receptors, LDL | 1 | 2024 | 488 | 0.050 |
Why?
|
| Infarction | 1 | 2022 | 248 | 0.050 |
Why?
|
| Endarterectomy | 1 | 2022 | 195 | 0.050 |
Why?
|
| Length of Stay | 3 | 2023 | 6476 | 0.050 |
Why?
|
| Graft Survival | 2 | 2022 | 3795 | 0.050 |
Why?
|
| Embolectomy | 1 | 2022 | 129 | 0.050 |
Why?
|
| Chemotaxis | 1 | 2024 | 598 | 0.050 |
Why?
|
| Prevalence | 1 | 2017 | 15686 | 0.040 |
Why?
|
| Atrial Fibrillation | 1 | 2019 | 5209 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2022 | 503 | 0.040 |
Why?
|
| Angiotensin II | 1 | 2022 | 849 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2024 | 22020 | 0.040 |
Why?
|
| Necrosis | 1 | 2023 | 1612 | 0.040 |
Why?
|
| Retrospective Studies | 6 | 2023 | 80345 | 0.040 |
Why?
|
| Waiting Lists | 1 | 2023 | 763 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 12289 | 0.040 |
Why?
|
| Databases, Bibliographic | 1 | 2018 | 130 | 0.040 |
Why?
|
| Aged | 9 | 2024 | 169143 | 0.040 |
Why?
|
| Isotonic Solutions | 1 | 2017 | 116 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2021 | 1635 | 0.040 |
Why?
|
| Registries | 2 | 2024 | 8458 | 0.030 |
Why?
|
| Galectin 3 | 1 | 2019 | 240 | 0.030 |
Why?
|
| Galectins | 1 | 2019 | 282 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2023 | 1336 | 0.030 |
Why?
|
| Female | 12 | 2022 | 391246 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2016 | 11890 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2017 | 524 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 1959 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 1827 | 0.030 |
Why?
|
| Blood | 1 | 2017 | 586 | 0.030 |
Why?
|
| Fibrosis | 1 | 2022 | 2042 | 0.030 |
Why?
|
| Adipocytes | 1 | 2022 | 1179 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2017 | 681 | 0.030 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2017 | 542 | 0.030 |
Why?
|
| Middle Aged | 8 | 2022 | 220359 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2023 | 3442 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2021 | 2129 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2024 | 58980 | 0.030 |
Why?
|
| Blood Proteins | 1 | 2019 | 1173 | 0.030 |
Why?
|
| Hormone Replacement Therapy | 1 | 2019 | 755 | 0.030 |
Why?
|
| Risk Factors | 2 | 2018 | 74333 | 0.030 |
Why?
|
| Mitral Valve | 1 | 2021 | 1486 | 0.030 |
Why?
|
| Thrombolytic Therapy | 1 | 2022 | 2108 | 0.030 |
Why?
|
| Reoperation | 1 | 2023 | 4289 | 0.030 |
Why?
|
| Child | 2 | 2017 | 79799 | 0.030 |
Why?
|
| RNA | 1 | 2022 | 2723 | 0.020 |
Why?
|
| Blood Loss, Surgical | 1 | 2015 | 656 | 0.020 |
Why?
|
| Aortic Valve | 1 | 2021 | 1996 | 0.020 |
Why?
|
| Algorithms | 2 | 2021 | 13982 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 4356 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2023 | 3539 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3802 | 0.020 |
Why?
|
| United States | 3 | 2023 | 72448 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2022 | 3300 | 0.020 |
Why?
|
| Leukocytes | 1 | 2017 | 2027 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2015 | 1895 | 0.020 |
Why?
|
| Macrophages | 1 | 2024 | 5745 | 0.020 |
Why?
|
| Adiposity | 1 | 2018 | 1858 | 0.020 |
Why?
|
| Linear Models | 1 | 2018 | 5877 | 0.020 |
Why?
|
| Bariatric Surgery | 1 | 2018 | 1005 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2018 | 5201 | 0.020 |
Why?
|
| Prognosis | 2 | 2019 | 29661 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2022 | 9288 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 6498 | 0.020 |
Why?
|
| Retina | 1 | 2017 | 2635 | 0.020 |
Why?
|
| Acute Disease | 1 | 2017 | 7268 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2021 | 8022 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 9530 | 0.020 |
Why?
|
| Heart | 1 | 2017 | 4393 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2017 | 6379 | 0.010 |
Why?
|
| Patient Selection | 1 | 2015 | 4279 | 0.010 |
Why?
|
| Inflammation | 1 | 2022 | 10755 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 15286 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13505 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2023 | 23374 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 18137 | 0.010 |
Why?
|
| Diet | 1 | 2017 | 8010 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2015 | 4783 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 39262 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 54306 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 58748 | 0.000 |
Why?
|
Concepts
(188)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_